- Ut imperdiet leo id lorem fermentum consectetur.
- Ut vitae orci et dui varius tincidunt.
- Ut id magna non libero vestibulum pharetra ac faucibus nulla.
Digital & Innovation
Report highlights digital health industry engagement with Australian regulatory framework

Digital & Innovation: Digital health technologies (DHTs) have the potential to disrupt both the medical technology, biotechnology and pharmaceutical sector and the broader delivery of healthcare, creating challenges for the effective and timely regulation of new therapeutic goods.
MTPConnect’s new report Adaptive Regulation for Digital Health: Enhancing Australia’s Regulation System examines how digital health industry stakeholders are engaging with the Australian therapeutic goods regulatory framework, using case studies to highlight the rapid and diverse development pathways for digital medical devices in Australia.
Focusing on DHTs regulated as medical devices – including software as a medical device (SaMD) and physical medical devices with associated software – the research has sought to cover the following:
- Ascertain the current state of knowledge regarding regulatory pathways and regulation compliance for DHTs;
- Identify key challenges in digital health regulation within the current regulatory framework;
- Identify potential alignments and misalignments between current regulatory requirements and new product development processes;
- Clarify how current regulatory policies and frameworks could accommodate an adaptive approach to digital health regulation; and
- Identify areas where greater education and awareness are needed within industry.
The research presented in this report was funded by MTPConnect and conducted by researchers at The University of Queensland’s (UQ) Australian Institute for Business and Economics (AIBE) with support from Steering Committee representatives from the Therapeutic Goods Administration, CSIRO, ANDHealth, University of Queensland and Allens.
Australia has an opportunity to take the global lead in ensuring timely consumer access to cutting-edge medical technologies. This report is critical reading for start-ups and innovators developing digital health technologies.
Click here to view the report.
Leadership & Management

The power of being an authentic leader
Leadership & Management: Welcome to Health Industry Hub’s Women in Leadership Series – connecting, engaging and empowering women in the […]
MoreDigital & Innovation

Data is the biggest challenge, and opportunity, for MedTech
Digital & Innovation: Medical technology is increasingly shaping the future of healthcare. The sector is also a growing part of […]
MoreNews & Trends - Medical Technology

Thermo Fisher acquisition to better serve its pharma and biotech clients
MedTech News: Thermo Fisher Scientific is buying clinical research services provider PPD for a hearty $17.4 billion, and that’s not its only acquisition this […]
MoreNews & Trends - Pharmaceuticals

First-in-class oncology drug candidate licensed by Aussie pharma
Pharma News: An Australian oncology-focused drug development company entered into a worldwide exclusive licensing agreement and a master services agreement […]
More